The MATCH Team at Brunel University held a CEOs’ breakfast hosted by the Vice-Chancellor, Professor Chris Jenks, on Wednesday March 24th 2010, at Brunel University.  The purpose of this private function was to inform Chief Executives and Senior Company Officers of the emerging results from the MATCH programme related to investment and pricing decisions in markets subject to value-for-money evaluation (such as those informed by NICE guidance).  We also solicited the views of our guests on how best to steer this highly promising research.

The rationale behind this topic is that, while manufacturers have become increasingly aware of the need to articulate the value of their technologies when bringing them to market – for instance in submitting evidence to a NICE appraisal, there has been limited scope for using this evidence to inform internal decisions.  Recently, however, methods have been developed to enable the same value-based thinking to be applied internally in deciding which technologies to invest in, how to manage risk along the product development pathway, or how to set prices.

MATCH is running a series of events that have proved to be a great networking opportunity for people within the healthcare industry.  This event extends the usual brief by focusing on the strategic implications of the MATCH Programme.